These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27760942)

  • 1. [Ethinylestradiol Following Everolimus plus Exemestane Was Effective in Postmenopausal Endocrine-Responsive Metastatic Breast Cancer - A Case Report].
    Matsuoka A; Hirano A; Hattori A; Ogura K; Inoue H; Yukawa H; Sakaguchi S; Tanaka N; Kodera A; Kamimura M; Naritaka Y; Shimizu T
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1219-1222. PubMed ID: 27760942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Long-Term Survival of Breast Cancer with Lymph Node and Liver Metastases Treated with Sequential Anti-HER2 Drugs, Chemotherapy, and Endocrine Therapy].
    Katsumori T; Ohshima H; Hamaguchi H; Yamamoto S; Tsukamoto Y; Iwanaga T; Ohkawara S
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1838-1840. PubMed ID: 29394793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An Elderly Patient with Metastatic Breast Cancer Who Developed Severe Adverse Events such as Stomatitis and Interstitial Pneumonia after Everolimus plus Exemestane Treatment].
    Sakiyama K; Yoshida T; Goto Y; Kimura M
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):753-5. PubMed ID: 27306814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Everolimus plus Exemestane in Postmenopausal Metastatic Breast Cancer Patients].
    Yamamoto D; Tsubota Y; Sueoka N; Yamamoto C; Kon M
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1319-21. PubMed ID: 26489585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Fulvestrant with Low-Dose Capecitabine is Effective and Tolerable in Woman with Metastatic Breast Cancer.
    Nakai M; Takei H; Yanagihara K; Yamashita K; Uchida E
    J Nippon Med Sch; 2016; 83(2):81-6. PubMed ID: 27180793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
    Kanada Y; Matsuzaki H; Kobayashi H; Suzuki K; Sawada H; Senba Y; Yoshioka T; Note H; Sato Y; Miyazaki A; Natsume T; Tanaka H; Maruyama T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1509-11. PubMed ID: 26805079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report.
    Ballatore Z; Pistelli M; Battelli N; Pagliacci A; De Lisa M; Berardi R; Cascinu S
    BMC Res Notes; 2016 Nov; 9(1):497. PubMed ID: 27894335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of estrogen receptor-positive metastatic breast cancer in a postmenopausal woman treated with ethinyl estradiol].
    Goto H; Inao T; Nakano M; Ibusuki M; Murakami K; Yamamoto Y; Iwase T
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2569-71. PubMed ID: 24335372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
    Inari H; Chiba A; Inaba M; Ino H; Fukahori M; Yoshida A
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):333-5. PubMed ID: 19223759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
    Generali D; Venturini S; Rognoni C; Ciani O; Pusztai L; Loi S; Jerusalem G; Bottini A; Tarricone R
    Breast Cancer Res Treat; 2015 Jul; 152(1):95-117. PubMed ID: 26044370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
    Chirila C; Mitra D; Colosia A; Ling C; Odom D; Iyer S; Kaye JA
    Curr Med Res Opin; 2017 Aug; 33(8):1457-1466. PubMed ID: 28463012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-Term Survival of a Patient with Stage IV Breast Cancer and An Intrathoracic Space-Occupying Metastatic Lesion].
    Koh T; Sakai T; Kato S; Hirajima S; Nishio M; Soga K; Oguro A; Nakagawa N
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2041-2043. PubMed ID: 28133215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and Safety of Everolimus plus Exemetane in Postmenopausal Endocrine-Responsive Metastatic Breast Cancer Patients].
    Maeda N; Yamamoto S; Sato Y; Sakamoto K; Suzuki N; Takeda S; Nagashima Y; Kubo H; Nagano H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1260-1262. PubMed ID: 29394600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
    Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subclavian Artery Hemorrhage Related to Everolimus in a Patient with Recurrent Breast Cancer--A Case Report].
    Kakimoto M; Nakata T; Imaizumi K; Hirano T; Murata T; Okuno K; Hoshino M; Matsuyama T; Goto H; Koshiishi H; Yoshimura T; Osanai T; Suzuki K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1806-8. PubMed ID: 26805179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of HER2-Positive Breast Cancer with Liver Metastases Showing Three Years of Complete Response to Combination Therapy with Trastuzumabplus Pertuzumab].
    Fujimoto Y; Yamaguchi K; Ueno A; Sakurai R; Nagahisa Y; Imai S; Kawamoto K
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):459-461. PubMed ID: 29650905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Recurrent Breast Cancer with Bone Metastasis Successfully Treated with Everolimus and Exemestane Therapy].
    Kubo H; Kimura Y; Kawaoka T; Miyahara M; Shimizu R; Nagashima Y; Yamamoto S; Nagano H
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):157-160. PubMed ID: 28223674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2].
    Ito Y; Masuda N; Iwata H; Mukai H; Horiguchi J; Tokuda Y; Kuroi K; Mori A; Ohno N; Noguchi S
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):67-75. PubMed ID: 25596682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.